Literature DB >> 12391369

Guillain-Barré syndrome following acute falciparum malaria.

Tag-Eldin O Sokrab1, Ammar Eltahir, Mohamed N A Idris, Murtada Hamid.   

Abstract

Plasmodium falciparum malaria is often complicated by involvement of the gastrointestinal, cardiovascular, and nervous systems. The development of Guillain-Barré syndrome in 10 patients who had had acute P. falciparum malaria during its seasonal exacerbation is reported.

Entities:  

Mesh：

Year:  2002        PMID： 12391369     DOI： 10.1212/wnl.59.8.1281

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  [Studies on low volume priming heart lung bypass (author's transl)].

Authors:  M Kawamura
Journal:  Hokkaido Igaku Zasshi       Date:  1975-03

2.  Lesson of the month 1: Post-malaria neurological syndromes.

Authors:  Michael D O'Brien; Tania Jagathesan
Journal:  Clin Med (Lond)       Date:  2016-06       Impact factor: 2.659

3.  Facial Diplegia in Plasmodium vivax Malaria.

Authors:  Jae Eun Sim; Young-Chul Choi; Won-Joo Kim
Journal:  J Clin Neurol       Date:  2010-06-30       Impact factor: 3.077

4.  Steroid Pulse Therapy May Mitigate Prolonged Neurological Manifestations after Eradication of Severe Plasmodium falciparum Parasitemia.

Authors:  Chihiro Hasegawa; Akiko Inagaki; Gohei Yamada; Koji Morita; Isamu Kitamura; Koya Ariyoshi
Journal:  Intern Med       Date:  2016-11-15       Impact factor: 1.271

5.  Falciparum malaria associated acute kidney injury with polyneuropathy and intra-arterial thrombosis (stroke).

Authors:  Nausheen Butt; Ejaz Ahmed
Journal:  Eur J Med Res       Date:  2022-01-06       Impact factor: 2.175

6.  Hypokalaemic paralysis in an adult case of Plasmodium vivax malaria.

Authors:  Sagar Sinha; Ananya Mukherji; Santwana Chandrakar
Journal:  Malar J       Date:  2013-03-26       Impact factor: 2.979

7.  Central nervous system infections in travelers.

Authors:  H L Kirsch; K T Thakur; G L Birbeck
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.663
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.